Name: induction and validation of cellular senescence in primary human cells
Uploaded: 2018-06-20T14:30:00.000+00:00
Duration: 8 min 18 s
Description: Watch this Scientific Journal Video about Induction and Validation of Cellular Senescence in Primary Human Cells at JoVE.com

我们感谢 Demaria 实验室的成员进行了卓有成效的讨论, 并 Thijmen van 弗利特共享关于紫外线诱发衰老的数据和协议。

1. 一般准备
<ol><li>准备 D10 培养基。补充 DMEM 中 Glutamax 与10% 血清和1% 青霉素/链霉素 (最后浓度: 100 U/毫升)。</li>
	<li>准备无菌 PBS。根据制造商的指示, 在水中溶解药片。用高压釜消毒。</li>
	<li>准备1x 胰蛋白酶。稀释5毫升的胰蛋白酶-Versene EDTA/10x 1:10 在45毫升的无菌 PBS。 注意: 在整个协议中, 我们使用的细胞培养条件, 更接近的生理条件, 主要成纤维细胞。这意味着, 我们孵化的细胞在37摄氏度和 5% CO2通常做, 但使用5% O2 而不是 "标准" 20% O2.
</li>
	<li>使用层流罩、实验室外套和手套处理所有灭菌条件下的样品。仅在处理时将单元格保持在 20% O2 (房间条件)。</li>
</ol>2. 衰老的诱导
<ol><li>复制衰老
	<ol>
<li>在处理细胞或任何与它们接触的材料 (滴管、烧瓶、介质等) 的情况下, 使用层流罩、实验室外套和手套在无菌条件下工作。仅在处理时将单元格保持在 20% O2 (房间条件)。</li>
		<li>种子 7 x 105可行的主要成纤维细胞在低人口加倍 (PD) 在一个 T75 烧瓶 (~ 9.3 x 103细胞/cm2) 包含10毫升的 D10。</li>
		<li>在细胞孵化器中生长37摄氏度的细胞, 5% CO2和 5% O2直到它们达到70–80% 汇合 (在低 PD 中增殖培养的3–4天)。</li>
		<li>使用3毫升1x 胰蛋白酶和孵化的细胞培养孵化器在37°c 与 5% CO2和 5% O25–7分钟。用细胞培养显微镜定期监测细胞, 检查分离过程。</li>
		<li>当细胞为球形时, 通过加入9毫升的 D10 来阻止胰蛋白酶的反应。不要孵化超过10分钟。</li>
		<li>旋转细胞在 300 x g 5 分钟的细胞将形成一个颗粒在底部的管, 而碎片和较小的颗粒将留在上清。</li>
		<li>移除上清液并将细胞颗粒溶解在1毫升的 D10 中, 并根据制造商的指示或 Neubauer 室进行手动计数, 并使用自动单元计数器进行细胞计数。在计数时, 包括检测细胞的生存能力 (例如, 台盼蓝排除23)。</li>
		<li>使用此公式计算累计 PD: PD新= 3.32 * (日志 (细胞数总计)-(日志 (细胞数种子) + PDold 细胞总数 = 所有细胞计数: 死和活。 细胞数种子 = 可存活细胞的数量 (8x105细胞)。 PD老= 在播种的那一刻人口加倍。 PD新= 人口加倍在计数的时刻 (在孵化以后)。 注: 如果 7 x 105原发性成纤维细胞 (PD 35.2) 在 T-75 瓶上播种, 并且, 在4天他们到达80% 汇合并且再被分裂, 现在计数 1.3 x 106总细胞 (死 + 活)。 PD新= 3.32 * (日志 (130万个单元格)-日志 (70万)) + 35。2 PD新= 36。1</li>
		<li>补种 8 x 105细胞在一个新的 T75, 重复步骤 2.1. 2–2.1. 8。 注意: 经过多次连续的通道, 在细胞停止分裂之前, 这种文化需要更长的时间才能汇合。一旦细胞停止分裂, 测试衰老标记和/或收获的下游应用。</li>
		<li>考虑到衰老细胞的大小可能会使这种文化显得丰满, 但细胞数量却很低。因此, 当 PD 稳定和其他衰老标记出现在文化中时, 可以假设衰老 (参见协议 3.1–3.5)。 注: 使用增殖的主成纤维细胞作为控制。</li>
	</ol></li>
	<li>电离辐射引起的衰老
	<ol>
<li>在处理细胞或任何与它们接触的材料 (滴管、烧瓶、介质等) 的同时, 使用层流罩、实验室外套和手套在无菌条件下工作。仅在处理时将单元格保持在 20% O2 (房间条件)。</li>
		<li>种子 7 x 105可行的主要成纤维细胞在一个低 PD 在一个 T75 瓶 (~ 9.3 x 103细胞/cm2) 包含10毫升的 D10。</li>
		<li>一夜之间孵化细胞培养孵化器在37°c 与 5% CO2和 5% O2。</li>
		<li>根据使用中机器的说明, 将细胞暴露在伽玛照射下10 灰。</li>
		<li>从细胞中吸取培养基, 并用10毫升的 D10。</li>
		<li>在10毫升的细胞培养孵化器中孵育细胞在37°c 与 5% CO2和 5% O2为另外10天通常, 大约每3天替换媒介 D10。</li>
		<li>10天后, 测试衰老标记和/或使用细胞的下游应用。 注: 使用同一 PD (辐照前) 增殖的原发成纤维细胞作为控制。</li>
	</ol></li>
	<li>紫外线 (紫外线) 辐射引起的衰老
	<ol>
<li>在处理细胞或任何与它们接触的材料 (滴管、烧瓶、介质等) 的同时, 使用层流罩、实验室外套和手套在无菌条件下工作。仅在处理时将单元格保持在 20% O2 (房间条件)。</li>
		<li>种子 1.5–2 x 105可行的初级成纤维细胞在一个低 PD 在一个6井板 (1.5–2.0 x 104细胞/cm2), 增加2毫升的 D10 培养基。</li>
		<li>放置细胞培养孵化器在37°c 与 5% CO2和 5% O2和允许他们坚持到塑料至少 5 h。</li>
		<li>从细胞中脱下培养基。把6井板放在紫外线辐射室中间, 然后把塑料盖子摘下来。照射与 UVB, 20–30 mJ/cm2。</li>
		<li>每井加2毫升培养基。</li>
		<li>在2毫升的细胞培养孵化器中孵育细胞在37°c 与 5% CO2和 5% O2为另外7天通常, 大约每3天替换媒介 D10。 注: 7 天后, 细胞可以测试衰老标志物, 用于下游应用。使用相同 PD (辐照前) 的增殖原发成纤维细胞作为控制。</li>
	</ol></li>
	<li>阿霉素致衰老
	<ol>
<li>准备1,000x 阿霉素库存解决方案: 在 1x PBS 制造250µM 的阿霉素, 过滤-消毒溶液和整除500µL 每不育管。将阿霉素储存在-80 摄氏度。</li>
		<li>在处理细胞或任何与它们接触的材料 (滴管、烧瓶、介质等) 的同时, 使用层流罩、实验室外套和手套在无菌条件下工作。仅在处理时将单元格保持在 20% O2 (房间条件)。</li>
		<li>种子 7 x 105可行的主要成纤维细胞在一个低 PD 在一个 T75 瓶 (~ 9.3 x 103细胞/cm2) 包含10毫升的 D10。</li>
		<li>一夜之间孵化细胞培养孵化器在37°c 与 5% CO2和 5% O2。</li>
		<li>稀释11µL 的1,000x 阿霉素股票溶液在11毫升的 D10 到最后浓度250 nM.
</li>
		<li>从细胞中吸取培养基, 用10毫升的 D10 + 阿霉素代替。</li>
		<li>培养细胞为确切地 24 h 在细胞文化孵化器在37°c 与 5% CO2和 5% O2。</li>
		<li>从细胞中吸取培养基, 用10毫升的 D10 仔细冲洗一次。</li>
		<li>在10毫升的 D10 中孵化细胞6天, 定期更换培养基, 大约每3天进行一次。</li>
		<li>在7天, 测试衰老标记和/或用于下游应用。 注: 作为控制, 使用相同 PD 的增殖原发成纤维细胞治疗24小时与车辆 (PBS) 1:1, 000 在 D10。</li>
	</ol></li>
	<li>氧化应激引起的衰老
	<ol>
<li>在处理细胞或任何与它们接触的材料 (滴管、烧瓶、介质等) 时, 使用层流罩、实验室外套和手套在无菌条件下工作。仅在处理时将单元格保持在 20% O2 (房间条件)。</li>
		<li>种子 7 x 105可行的主要成纤维细胞在一个低 PD 在一个 T75 瓶 (~ 9.3 x 103细胞/cm2) 包含10毫升的 D10。</li>
		<li>一夜之间孵化细胞孵化器在37°c 与 5% CO2和 5% O2。</li>
		<li>在11毫升的 D10 中加入 22.6 ul 30% 过氧化氢, 在 D10 介质中制备200微米的过氧化氢溶液。 注: 通过作出曲线剂量-反应来评估毒性, 优化细胞类型的治疗。</li>
		<li>从细胞中吸取培养基, 加入10毫升的新制备的 D10 培养基 + 过氧化氢。孵育2小时在37°c 与 5% CO2和 5% O2。</li>
		<li>从细胞中吸取培养基, 用新鲜的 D10 清洗一次,不含过氧化氢。</li>
		<li>添加10毫升的 D10没有过氧化氢。</li>
		<li>孵育48小时在细胞培养孵化器在37°c 与 5% CO2和 5% O2。</li>
		<li>重复步骤 2.5. 4–2.5 8 次, 共三项治疗。</li>
		<li>检查下游应用的衰老标志或收获。 注: 作为对照, 使用 D10 中22.6 µL 的无菌水在2小时内治疗同一 PD 的增殖细胞。</li>
	</ol></li>
	<li>Epigenetically 引起的衰老
	<ol>
<li>根据表 1准备用于小分子的库存和工作解决方案。过滤-消毒解决方案。整除在无菌管中。存储在-20 摄氏度。</li>
		<li>在处理细胞或任何与它们接触的材料 (滴管、烧瓶、介质等) 的情况下, 在无菌条件下工作, 例如使用层流罩、实验室外套和手套。仅在处理时将单元格保持在 20% O2 (房间条件)。</li>
		<li>种子 7 x 105可行的主要成纤维细胞在一个低 PD 在一个 T75 瓶 (~ 9.3 x 103细胞/cm2) 包含10毫升的 D10。</li>
		<li>一夜之间孵化细胞培养孵化器在37°c 与 5% CO2和 5% O2。</li>
		<li>准备11毫升的 D10 中等 + 工作解决方案, 为理想的治疗。每治疗的确切稀释可以在表 1中看到。<ol>
<li>在11毫升的 D10 中准备11µL 1 毫米的萨哈工作溶液。</li>
			<li>在11毫升的 D10 中制备44µL 1 米丁酸钠工作溶液。</li>
			<li>在11毫升的 D10 中准备11µL 10 毫米 5 aza 工作溶液。 注意: 例如, 对细胞类型的兴趣进行优化处理, 比如对毒性进行曲线剂量反应。</li>
		</ol>
</li>
		<li>添加 D10 中 + 工作解决方案, 为所需的文化治疗。</li>
		<li>孵育24小时在细胞培养孵化器在37°c 与 5% CO2和 5% O2。</li>
		<li>重复步骤 2.6. 4–2.6 6 倍, 总共三种治疗方法。</li>
		<li>改变培养基为简单的 D10 没有药物。</li>
		<li>3天后, 细胞变得衰老, 并准备测试衰老标志物和下游应用。 注: 作为对照, 使用 D10 中 + 车治疗三天的同一 PD 的增殖性原发成纤维细胞。在这三天内, D10 中 + 车需要每24小时刷新一次。该车取决于所使用的治疗方法: 1:1, 000 亚砜为萨哈和 5-aza 和1:250 无菌水的丁酸钠。</li>
	</ol></li>
</ol>3. 衰老的标志物
<ol><li>制备
	<ol>
<li>准备20毫克/毫升 x-加仑: 溶解20毫克的 x 加仑在1毫升的甲基酰胺或亚砜。贮存在-20 摄氏度, 免受光照。</li>
		<li>准备 0.1 M 柠檬酸溶液: 在100毫升的水中溶解2.1 克柠檬酸一水合物。在室温下贮存。</li>
		<li>制备0.2 米磷酸钠溶液: 溶解2.84 克磷酸二钠或3.56 克磷酸二钠, 在100毫升水中脱水。在室温下贮存。</li>
		<li>准备0.2 米柠檬酸/磷酸磷酸钠 pH 值 6.0: 溶解36.85 毫升 0.1 M 柠檬酸溶液和63.15 毫升的0.2 米磷酸钠。完全调整到 pH 值 6.0。在室温下贮存。</li>
		<li>准备100毫米盐钾: 盐50毫升水中溶解2.1 克钾。贮存在4摄氏度, 免受光照。</li>
		<li>准备100毫米氰化钾钾: 氰化钾50毫升水中溶解1.7 克钾。贮存在4摄氏度, 免受光照。</li>
		<li>准备5米氯化钠: 在50毫升水中溶解14.6 克氯化钠。在室温下贮存。</li>
		<li>准备1米氯化镁: 在50毫升的水中溶解4.8 克氯化镁。在室温下贮存。</li>
		<li>在 pbs 中制备2% 甲醛 + 0.2% 戊二醛: 在 pbs 的 12.5 ul 中溶解800µL 25% 戊二醛和16% µL 100 甲醛。在室温下贮存, 免受光线的侵害。</li>
		<li>根据 表 2准备新的染色液。
</li>
	</ol></li>
	<li>衰老相关β-乳糖酶染色
	<ol>
<li>对于每个样本, 种子 1 x 104细胞在24井板 (5.2 x 103细胞/cm2) 的至少一个井中包含500µL 的 D10, 使细胞稀疏。治疗 (如果适用的话) 可以直接在这个盘子上进行, 或者, 已经被治疗的细胞可以被重新播种到24井板中。</li>
		<li>一夜之间孵化细胞在37°c 与 5% CO2和 5% O2。</li>
		<li>用 500 ul 的 PBS 冲洗细胞两次。</li>
		<li>在室温下使用 500 ul/井2% 甲醛 + 0.2% 戊二醛在 PBS 中固定3–5分钟。</li>
		<li>用 500 ul 的 PBS 冲洗细胞两次。</li>
		<li>准备新的染色液, 根据样品的数量进行染色。</li>
		<li>添加染色液 (500 µL/井), 用 parafilm 密封板, 避免蒸发。 注: 蒸发可能导致晶体形成和阻碍观察在显微镜下。</li>
		<li>在黑暗中孵化细胞 (例如用铝箔覆盖) 在干燥的孵化器 (没有 CO2) 为 12–16 h 的37摄氏度。 注: CO2可能影响 pH 值, 因此修改结果。某些细胞类型可能需要更短的孵化时间。</li>
		<li>洗两次与 500 ul 的 PBS。</li>
		<li>评估结果。阳性细胞在正常的光显微镜下呈现蓝色 (主要是) 核周染色 (图 1A)。</li>
		<li>为定量, 观察每个样本至少100个细胞和计数阳性细胞的数量。由于衰老细胞改变形状, 通常很难定义细胞边界和计数细胞。Counterstain 与 DAPI, 以促进个别细胞的可视化和量化 (图 1B)。使用荧光显微镜 (图 1C) 量化样本 (阳性细胞与总数量的百分比)。拍摄同一样本的多个图片, 以便在最后你可以数至少100单细胞和评估 SA β-gal 阳性细胞的百分比。</li>
		<li>比较衰老细胞的结果与相应的治疗方法的对照。 注: 在同一个样本上与教育局的共同染色是可能的。认为细胞应该在盖玻片上播种。</li>
	</ol></li>
	<li>留学合并化验
	<ol>
<li>根据样品数量, 将盖玻片/井放在24井板上进行评估。</li>
		<li>种子 1 x 104细胞在一个24井板 (5.2 x 103细胞/cm2) 的至少一个井中, 每个条件包含500µL 的 D10, 使细胞稀疏。治疗 (如果适用的话) 可以直接在这个盘子上进行, 或者, 已经处理过的细胞可以被重新播种到24井板中。</li>
		<li>一夜之间孵化细胞在37°c 与 5% CO2和 5% O2。</li>
		<li>根据要处理的样品数量 (每样品250个 ul), 在 D10 (1:250) 中制作20µM 解决方案。</li>
		<li>从每个井中取出一半的介质 (250 ul), 用刚刚准备好的 D10 解决方案来处理并替换它。最终的µM 浓度是10。</li>
		<li>孵化 18–24 h 在细胞培养孵化器在37°c 与 5% CO2和 5% O2。在控制和衰老细胞中使用相同的孵化时间。</li>
		<li>用 500 ul 的 PBS 洗涤2x。</li>
		<li>固定细胞为10分钟与 500 ul 4% 甲醛在 PBS。</li>
		<li>孵育5分钟在 500 ul 100 毫米 (pH 7.6)。</li>
		<li>Permeabilize 10 分钟的细胞在 500 ul 0.1% 海卫 X-100 在 PBS。</li>
		<li>用 PBS 洗3x。</li>
		<li>为每个盖玻片准备 50 ul 标签组合, 按以下顺序添加组件: 44.45 µL 的 PBS, 0.5 µL 铜 (II),4, 0.05 µL sulfo-Cy3-azide, 5 µL 钠抗坏血酸。</li>
		<li>把 50 ul 的标签组合在一块 parafilm。用一双镊子和一根针举起盖玻片, 让它在标签混合的顶部休息, 表面上含有向下的细胞。确保没有气泡, 盖玻片的整个表面都在接触标签组合。在黑暗中孵化30分钟。</li>
		<li>把这些细胞放回24井板井中, 用 PBS 冲洗三次。</li>
		<li>安装与安装介质 (包括 DAPI, 以可视化原子核) 到玻璃幻灯片, 让他们干一夜。</li>
		<li>使用荧光显微镜可视化了该公司的注册。使用适合 Cy3 的过滤器 (激发/发射: 552/570 nm)。</li>
		<li>拍摄细胞的多张图片, 以便在每个条件下至少有100个细胞 (Cy3 和 DAPI) 进行量化。</li>
		<li>使用以下公式量化纳入教育局的单元格百分比: 教育局阳性细胞 (%) = (教育局阳性细胞计数 (Cy3)/总细胞计数 (DAPI)) * 100</li>
		<li>比较衰老细胞的结果与相应的治疗方法的对照。 注: 在同一样品上与 SA β-gal 进行共染色是可能的。认为细胞仍应在盖玻片上播种。</li>
	</ol></li>
	<li>p16、p21 和 SASP 的基因表达
	<ol>
<li>准备一组感兴趣的基因 (50 µM 每个底漆)。 注: p16、p21 及相关 SASP 因素的 qPCR 是衰老状态的信息。本文所描述的协议使用通用探针库 (价目表) 系统进行相对量化, 使用实时 PCR。表 3显示了用于检测 CDK 抑制剂 p16 和 p21 以及最相关 SASP 成员的底漆的概述, 以及蛋白和肌动蛋白, 作为该化验的参考基因。表 3的最后一列登记用于每种化验的特定价目表探针。</li>
		<li>为所需的化验准备单独的 qPCR 反应组合。总是包括参考基因以及根据表 4。</li>
		<li>以重复或三份运行所有示例。</li>
		<li>负载7.5 µL/井的 qPCR 反应混合在一个384井板上。</li>
		<li>添加〜5的 cDNA 溶解在2.5 µL 的无 RNase 水。 注意: 最好有类似数量的 cDNA 的所有样本进行比较。这可以通过使用相同数量的 RNA 来实现反向转录。</li>
		<li>用密封盖住盘子, 确保它正确地覆盖在盘子上的所有油井。</li>
		<li>旋转板在 2000 x g 1 分钟。</li>
		<li>使用以下协议在 Lightcycler 中运行40个周期的板块: 95°c 为7分钟 40周期95°c 为 5 s 和60°c 为三十年代 37°c 为1分钟</li>
		<li>为了对结果进行分析, 使用建议的方法对 Livak 和同事分析 qPCR 数据24。使用蛋白或肌动蛋白作为参考基因计算ΔCt 值, 并使用适当的控制来计算ΔΔCt 价值的特定的衰老诱导治疗。</li>
	</ol></li>
	<li>IL6 蛋白的表达与分泌
	<ol>
<li>种子 5–10 x 104细胞在6井板 (5.2–10.5 x 103细胞/cm2) 的至少一个井中, 每个条件包含2毫升的 D10。治疗 (如果适用的话) 可以直接在这个盘子上进行, 或者, 已经被治疗的细胞可以被重新播种到24井板中。让它在播种后一夜之间站立。</li>
		<li>取出培养基并更换2毫升的 DMEM 培养基,不加血清。正常条件下孵育24小时。</li>
		<li>在15毫升管中收集培养基。</li>
		<li>离心机样品在 300 x g 为5分钟培养基可以保存在-80 °c, 直到处理。</li>
		<li>按照制造商的指示执行 ELISA。</li>
		<li>衰老细胞相对于特定衰老诱导治疗的适当控制结果比较</li>
	</ol></li>
</ol>

<ol>
	<li>Hayflick, L., Moorhead, P. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+serial+cultivation+of+human+diploid+cell+strains.">The serial cultivation of human diploid cell strains.</a> Experimental Cell Research. 25, 585-621 (1961).</li><li>Mu&#241;oz-Esp&#237;n, D., Serrano, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cellular+senescence:+from+physiology+to+pathology.+Nature+reviews.">Cellular senescence: from physiology to pathology. Nature reviews.</a> Molecular cell biology. 15, 482-496 (2014).</li><li>Sharpless, N. E., Sherr, C. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Forging+a+signature+of+in+vivo+senescence.">Forging a signature of in vivo senescence.</a> Nature Reviews Cancer. 15 (7), 397-408 (2015).</li><li>Correia-Melo, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mitochondria+are+required+for+pro-ageing+features+of+the+senescent+phenotype.">Mitochondria are required for pro-ageing features of the senescent phenotype.</a> The EMBO Journal. 10, e201592862 (2016).</li><li>Loaiza, N., Demaria, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cellular+senescence+and+tumor+promotion:+Is+aging+the+key?.">Cellular senescence and tumor promotion: Is aging the key?.</a> Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. , (2016).</li><li>Coppe, J. P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Senescence-associated+secretory+phenotypes+reveal+cell-nonautonomous+functions+of+oncogenic+RAS+and+the+p53+tumor+suppressor.">Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor.</a> PLoS Biology. 6 (12), 2853-2868 (2008).</li><li>Baker, D. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Naturally+occurring+p16(Ink4a)-positive+cells+shorten+healthy+lifespan.">Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan.</a> Nature. 530 (7589), 184-189 (2016).</li><li>Xu, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Targeting+senescent+cells+enhances+adipogenesis+and+metabolic+function+in+old+age.">Targeting senescent cells enhances adipogenesis and metabolic function in old age.</a> Elife. 4, e12997 (2015).</li><li>Baker, D. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Clearance+of+p16Ink4a-positive+senescent+cells+delays+ageing-associated+disorders.">Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders.</a> Nature. 479 (7372), 232-236 (2011).</li><li>Jeon, O. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Local+clearance+of+senescent+cells+attenuates+the+development+of+post-traumatic+osteoarthritis+and+creates+a+pro-regenerative+environment.">Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment.</a> Nature Medicine. 23 (6), 775-781 (2017).</li><li>Demaria, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cellular+Senescence+Promotes+Adverse+Effects+of+Chemotherapy+and+Cancer+Relapse.">Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse.</a> Cancer Discovery. 7 (2), 165-176 (2017).</li><li>Chang, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Clearance+of+senescent+cells+by+ABT263+rejuvenates+aged+hematopoietic+stem+cells+in+mice.">Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice.</a> Nature Medicine. 22 (1), 78-83 (2016).</li><li>Soto-Gamez, A., Demaria, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Therapeutic+interventions+for+aging:+the+case+of+cellular+senescence.">Therapeutic interventions for aging: the case of cellular senescence.</a> Drug Discov Today. 22 (5), 786-795 (2017).</li><li>Childs, B. G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Senescent+cells:+an+emerging+target+for+diseases+of+ageing.">Senescent cells: an emerging target for diseases of ageing.</a> Nature Reviews Drug Discovery. 16 (10), 718-735 (2017).</li><li>Marthandan, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Conserved+genes+and+pathways+in+primary+human+fibroblast+strains+undergoing+replicative+and+radiation+induced+senescence.">Conserved genes and pathways in primary human fibroblast strains undergoing replicative and radiation induced senescence.</a> Biological Research. 49, 34 (2016).</li><li>Marthandan, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Conserved+Senescence+Associated+Genes+and+Pathways+in+Primary+Human+Fibroblasts+Detected+by+RNA-Seq.">Conserved Senescence Associated Genes and Pathways in Primary Human Fibroblasts Detected by RNA-Seq.</a> PLoS One. 11 (5), e0154531 (2016).</li><li>Hernandez-Segura, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Unmasking+Transcriptional+Heterogeneity+in+Senescent+Cells.">Unmasking Transcriptional Heterogeneity in Senescent Cells.</a> Current Biology. 27 (17), 2652-2660 (2017).</li><li>Le, O. N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Ionizing+radiation-induced+long-term+expression+of+senescence+markers+in+mice+is+independent+of+p53+and+immune+status.">Ionizing radiation-induced long-term expression of senescence markers in mice is independent of p53 and immune status.</a> Aging Cell. 9 (3), 398-409 (2010).</li><li>Hall, J. R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=C/EBPalpha+regulates+CRL4(Cdt2)-mediated+degradation+of+p21+in+response+to+UVB-induced+DNA+damage+to+control+the+G1/S+checkpoint.">C/EBPalpha regulates CRL4(Cdt2)-mediated degradation of p21 in response to UVB-induced DNA damage to control the G1/S checkpoint.</a> Cell Cycle. 13 (22), 3602-3610 (2014).</li><li>Nitiss, J. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Targeting+DNA+topoisomerase+II+in+cancer+chemotherapy.">Targeting DNA topoisomerase II in cancer chemotherapy.</a> Nature Reviews Cancer. 9 (5), 338-350 (2009).</li><li>Pazolli, E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Chromatin+remodeling+underlies+the+senescence-+associated+secretory+phenotype+of+tumor+stromal+fibroblasts+that+supports+cancer+progression.">Chromatin remodeling underlies the senescence- associated secretory phenotype of tumor stromal fibroblasts that supports cancer progression.</a> Cancer Research. 72, 2251-2261 (2012).</li><li>Venturelli, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Differential+induction+of+apoptosis+and+senescence+by+the+DNA+methyltransferase+inhibitors+5-azacytidine+and+5-aza-2'-deoxycytidine+in+solid+tumor+cells.">Differential induction of apoptosis and senescence by the DNA methyltransferase inhibitors 5-azacytidine and 5-aza-2'-deoxycytidine in solid tumor cells.</a> Molecular Cancer Therapeutics. 12, 2226-2236 (2013).</li><li>Tennant, J. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Evaluation+of+the+Trypan+Blue+Technique+for+Determination+of+Cell+Viability.">Evaluation of the Trypan Blue Technique for Determination of Cell Viability.</a> Transplantation. 2, 685-694 (1964).</li><li>Livak, K. J., Schmittgen, T. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Analysis+of+relative+gene+expression+data+using+real-time+quantitative+PCR+and+the+2(-Delta+Delta+C(T))+Method.">Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.</a> Methods. 25 (4), 402-408 (2001).</li><li>Lee, B. Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Senescence-associated+&#946;-galactosidase+is+lysosomal+&#946;-galactosidase.">Senescence-associated &#946;-galactosidase is lysosomal &#946;-galactosidase.</a> Aging Cell. 5, 187-195 (2006).</li><li>Kopp, H. G., Hooper, A. T., Shmelkov, S. V., Rafii, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Beta-galactosidase+staining+on+bone+marrow.+The+osteoclast+pitfall.">Beta-galactosidase staining on bone marrow. The osteoclast pitfall.</a> Histology and Histopathology. 22 (9), 971-976 (2007).</li><li>Dimri, G. P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+biomarker+that+identifies+senescent+human+cells+in+culture+and+in+aging+skin+in+vivo.">A biomarker that identifies senescent human cells in culture and in aging skin in vivo.</a> Proceedings of the National Academy of Sciences. 92 (20), 9363-9367 (1995).</li><li>Salic, A., Mitchison, T. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+chemical+method+for+fast+and+sensitive+detection+of+DNA+synthesis+in+vivo.">A chemical method for fast and sensitive detection of DNA synthesis in vivo.</a> Proceedings of the National Academy of Sciences. 105 (7), 2415-2420 (2008).</li><li>Sherr, C. J., McCormick, F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+RB+and+p53+pathways+in+cancer.">The RB and p53 pathways in cancer.</a> Cancer Cell. 2 (2), 103-112 (2002).</li><li>Bunz, F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Requirement+for+p53+and+p21+to+sustain+G2+arrest+after+DNA+damage.">Requirement for p53 and p21 to sustain G2 arrest after DNA damage.</a> Science. 282 (5393), 1497-1501 (1998).</li><li>Severino, J., Allen, R. G., Balin, S., Balin, A., Cristofalo, V. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Is+beta-galactosidase+staining+a+marker+of+senescence+in+vitro+and+in+vivo.">Is beta-galactosidase staining a marker of senescence in vitro and in vivo.</a> Experimental Cell Research. 257 (1), 162-171 (2000).</li><li>Stolzing, A., Coleman, N., Scutt, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Glucose-induced+replicative+senescence+in+mesenchymal+stem+cells.">Glucose-induced replicative senescence in mesenchymal stem cells.</a> Rejuvenation Research. 9 (1), 31-35 (2006).</li><li>Blazer, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=High+glucose-induced+replicative+senescence:+point+of+no+return+and+effect+of+telomerase.">High glucose-induced replicative senescence: point of no return and effect of telomerase.</a> Biochemical and Biophysical Research Communications. 296 (1), 93-101 (2002).</li><li>Wiley, C. D., Campisi, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=From+Ancient+Pathways+to+Aging+Cells-Connecting+Metabolism+and+Cellular+Senescence.">From Ancient Pathways to Aging Cells-Connecting Metabolism and Cellular Senescence.</a> Cell Metabolism. 23 (6), 1013-1021 (2016).</li><li>Kumar, R., Gont, A., Perkins, T. J., Hanson, J. E. L., Lorimer, I. A. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Induction+of+senescence+in+primary+glioblastoma+cells+by+serum+and+TGFbeta.">Induction of senescence in primary glioblastoma cells by serum and TGFbeta.</a> Scientific Reports. 7 (1), 2156 (2017).</li><li>Hypoxia Blagosklonny, M. V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=MTOR+and+autophagy:+converging+on+senescence+or+quiescence.">MTOR and autophagy: converging on senescence or quiescence.</a> Autophagy. 9 (2), 260-262 (2013).</li><li>Meuter, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Markers+of+cellular+senescence+are+elevated+in+murine+blastocysts+cultured+in+vitro:+molecular+consequences+of+culture+in+atmospheric+oxygen.">Markers of cellular senescence are elevated in murine blastocysts cultured in vitro: molecular consequences of culture in atmospheric oxygen.</a> Journal of Assisted Reproduction and Genetics. 31 (10), 1259-1267 (2014).</li><li>Coppe, J. P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+human-like+senescence-associated+secretory+phenotype+is+conserved+in+mouse+cells+dependent+on+physiological+oxygen.">A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen.</a> PLoS One. 5 (2), e9188 (2010).</li><li>van Deursen, J. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+role+of+senescent+cells+in+ageing.">The role of senescent cells in ageing.</a> Nature. 509 (7501), 439-446 (2014).</li><li>Kim, Y. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Implications+of+time-series+gene+expression+profiles+of+replicative+senescence.">Implications of time-series gene expression profiles of replicative senescence.</a> Aging Cell. 12, 622-634 (2013).</li></ol>

这里解释的协议被优化了为人的主要成纤维细胞, 特别是 BJ 和 WI-38 细胞。复制衰老, 电离辐射和阿霉素的协议已成功地应用于其他类型的成纤维细胞 (HCA2 和 IMR90) 和其他细胞类型 (即新生儿黑色素细胞和角质形成素或 iPSC 衍生心肌细胞)在我们的实验室里。然而, 可以通过调整一些细节, 如种子细胞数量, 方法和化学物质来帮助细胞附着/分离到塑料支架上, 以及治疗的剂量以避免毒性, 来优化其他细?...

在 1961年, 佛烈克和穆尔黑德报告说, 在连续1段后, 培养的主要成纤维细胞失去了增殖潜能。这一过程是由每细胞分裂后端粒的顺序缩短引起的。当端粒到达临界短的长度时, 它们被 DNA 损伤反应 (DDR) 所识别, 它激活了不可逆转的增殖--也被定义为复制衰老。复制衰老是目前已知的许多刺激之一, 导致一个永久性细胞周期逮捕的状态, 使细胞不敏感的 mitogens 和凋亡信号2,3。衰老程序通常的特点是额外的功能, 包括高溶酶活性, 线粒体功能障碍, 核变化, 染色质重组, 内质网应力, DNA 损伤和衰老相关分泌表型 (SASP)3,4。衰老细胞在体内具有多种功能: 发育、创面愈合和肿瘤抑制2。同样, 众所周知, 它们在衰老和肿瘤进展5中起着重要的作用。衰老的消极和部分矛盾的影响通常归因于 SASP6。
最近, 它表明, 消除衰老细胞的小鼠导致寿命延长和消除许多老化功能7,8,9,10,11,12. 同样, 已经开发了多种药物, 以消除衰老细胞 (senolytics) 或靶向 SASP13,14。抗衰老治疗潜力最近引起了人们的广泛关注。
对细胞衰老相关机制的研究和药理干预的筛选严重依赖于体外模型, 特别是在人原代成纤维细胞中。虽然不同的衰老诱导因子激活了一些共同的特征, 但衰老表型的大变异性被观察到, 并依赖于各种因素, 包括细胞类型, 刺激和时间点3,15, 16,17。研究和定位衰老细胞的异质性是当务之急。因此, 本议定书的目的是提供一系列方法, 以诱发衰老的主要成纤维细胞使用不同的治疗。正如它将解释, 这些方法可以很容易地适应其他细胞类型。
除了复制衰老, 我们还描述了其他五种衰老诱导治疗: 电离辐射, 紫外线 (紫外线) 辐射, 阿霉素, 氧化应激和后生变化 (即促进组蛋白乙酰化或 DNA 去甲基化).电离辐射和紫外线辐射直接导致 DNA 损伤, 并在适当剂量下引发衰老18,19。阿霉素还导致衰老主要是通过锂 dna 损伤的 dna 和干扰拓扑异构酶 II 功能, 从而停止 DNA 修复机制20。衰老的关键基因表达通常由组蛋白乙酰化和 DNA 甲基化控制。因此, 组蛋白乙酰抑制剂 (如丁酸钠和萨哈) 和 DNA 去甲基化 (例如, 5-aza) 剂会导致正常细胞21,22的衰老。
最后, 与衰老细胞相关的四种最常见的标记将被解释为: 衰老相关的乳糖酶 (SA β) 的活性、由免疫组织测定的 DNA 合成率、细胞周期调节器的过度表达和细胞周期蛋白依赖性激酶抑制剂 p16 和 p21, 并表达和分泌的 SASP 成员。

<table><tbody><tr><td>DMEM Media - GlutaMAX</td><td>Gibco</td><td>31966-047</td><td></td></tr><tr><td>Fetal Bovine Serum</td><td>Hyclone</td><td>SV30160.03</td><td></td></tr><tr><td>Penicillin-Streptomycin (P/S; 10,000 U/ml)</td><td>Lonza</td><td>DE17-602E</td><td></td></tr><tr><td>Dimethyl Sulfoxide (DMSO)</td><td>Sigma-Aldrich</td><td>SC-202581</td><td></td></tr><tr><td>Nuclease-Free Water (not DEPC-Treated)</td><td>Ambion</td><td>AM9937</td><td></td></tr><tr><td>T75 flask</td><td>Sarstedt</td><td>833911002</td><td></td></tr><tr><td>Trypsin/EDTA Solution</td><td>Lonza</td><td>CC-5012</td><td></td></tr><tr><td>PBS tablets</td><td>Gibco</td><td>18912-014</td><td></td></tr><tr><td>1.5 ml microcentrifuge tubes</td><td>Sigma-Aldrich</td><td>T9661-1000EA</td><td></td></tr><tr><td>Corning&amp;nbsp;15 mL centrifuge tubes</td><td>Sigma-Aldrich</td><td>CLS430791</td><td></td></tr><tr><td>6-well plate</td><td>Sarstedt</td><td>83.3920</td><td></td></tr><tr><td>24-well plate</td><td>Sarstedt</td><td>83.3922</td><td></td></tr><tr><td>13mm round coverslips</td><td>Sarstedt</td><td>83.1840.002</td><td></td></tr><tr><td>Steriflip</td><td>Merck Chemicals</td><td>SCGP00525</td><td></td></tr><tr><td>Cesium137-source</td><td></td><td></td><td>IBL 637 Cesium-137&amp;gamma;-ray machine</td></tr><tr><td>UV radiation chamber</td><td></td><td></td><td>Opsytec, Dr. G&amp;ouml;bel BS-02</td></tr><tr><td>Doxorubicin dihydrochloride&amp;nbsp;</td><td>BioAustralis Fine Chemicals</td><td>BIA-D1202-1</td><td></td></tr><tr><td>Hydrogen peroxide solution</td><td>Sigma-Aldrich</td><td>7722-84-1</td><td></td></tr><tr><td>5-aza-2&amp;rsquo;-deoxycytidine</td><td>Sigma-Aldrich</td><td>A3656</td><td></td></tr><tr><td>SAHA</td><td>Sigma-Aldrich</td><td>SML0061</td><td></td></tr><tr><td>Sodium Butyrate&amp;nbsp;</td><td>Sigma-Aldrich</td><td>B5887</td><td></td></tr><tr><td>X-gal (5-Bromo-4-chloro-3-indolyl-&amp;beta;-D-galactopyranoside)</td><td>Fisher Scientific</td><td>7240-90-6</td><td></td></tr><tr><td>Citric acid monohydrate</td><td>Sigma-Aldrich</td><td>5949-29-1</td><td></td></tr><tr><td>Sodium dibasic phosphate</td><td>Acros organics</td><td>7782-85-6</td><td></td></tr><tr><td>Potassium ferrocyanide&amp;nbsp;</td><td>Fisher Scientific</td><td>14459-95-1</td><td></td></tr><tr><td>Potassium ferricyanide</td><td>Fisher Scientific</td><td>13746-66-2</td><td></td></tr><tr><td>Sodium Chloride</td><td>Merck Millipore</td><td>7647-14-5</td><td></td></tr><tr><td>Magnesium Chloride</td><td>Fisher Chemicals</td><td>7791-18-6</td><td></td></tr><tr><td>25% glutaraldehyde</td><td>Fisher Scientific</td><td>111-30-8,7732-18-5</td><td></td></tr><tr><td>16% formaldehyde (w/v)</td><td>Thermo-Fisher Scientific</td><td>28908</td><td></td></tr><tr><td>EdU (5-ethynyl-2&amp;rsquo;-deoxyuridine)</td><td>Lumiprobe</td><td>10540</td><td></td></tr><tr><td>Sulfo-Cyanine3 azide (Sulfo-Cy3-Azide)</td><td>Lumiprobe</td><td>D1330</td><td></td></tr><tr><td>Sodium ascorbate</td><td>Sigma-Aldrich</td><td>A4034</td><td></td></tr><tr><td>Copper(II) sulfate pentahydrate (Cu(II)SO&lt;sub&gt;4&lt;/sub&gt;.5H&lt;sub&gt;2&lt;/sub&gt;O)</td><td>Sigma-Aldrich</td><td>209198</td><td></td></tr><tr><td>Triton X-100</td><td>Acros organics</td><td>215682500</td><td></td></tr><tr><td>TRIS base</td><td>Roche</td><td>11814273001</td><td></td></tr><tr><td>LightCycler 480 Multiwell Plate 384, white&amp;nbsp;</td><td>Roche</td><td>4729749001</td><td></td></tr><tr><td>Lightcycler 480 sealing foil&amp;nbsp;</td><td>Roche</td><td>4729757001</td><td></td></tr><tr><td>Sensifast Probe Lo-ROX kit&amp;nbsp;</td><td>Bioline</td><td>BIO-84020</td><td></td></tr><tr><td>UPL Probe Library</td><td>Sigma-Aldrich</td><td>Various</td><td></td></tr><tr><td>Human IL-6 DuoSet ELISA</td><td>R&amp;amp;D</td><td>D6050</td><td></td></tr><tr><td>Bio-Rad TC20</td><td>Bio-Rad</td><td></td><td></td></tr><tr><td>Counting slides</td><td>Bio-Rad</td><td>145-0017</td><td></td></tr><tr><td>Dry incubator</td><td>Thermo-Fisher Scientific</td><td>Heratherm</td><td></td></tr><tr><td>Dimethylformamide</td><td>Merck Millipore</td><td>1.10983</td><td></td></tr><tr><td>Parafilm &#039;M&#039; laboratory film</td><td>Bemis&amp;nbsp;</td><td>#PM992</td><td></td></tr><tr><td>Tweezers</td><td></td><td></td><td></td></tr><tr><td>Needles</td><td></td><td></td><td></td></tr></tbody></table>

induction and validation of cellular senescence in primary human cells

细胞衰老是一种永久性细胞周期停止激活的反应, 以应对不同的破坏性刺激。细胞衰老的活化是各种病理生理条件的标志, 包括肿瘤抑制、组织重塑和衰老。细胞衰老的诱导体在体内仍然缺乏特征。然而, 一些刺激可以用来促进细胞衰老前体。其中, 最常见的衰老诱导因子是复制衰竭, 电离和非电离辐射, 毒性药物, 氧化应激, 去甲基化和乙酰剂。在这里, 我们将提供有关如何使用这些刺激诱导成纤维细胞衰老的详细说明。该协议可以很容易地适应不同类型的主要细胞和细胞系, 包括癌细胞。我们还描述了不同的方法来验证衰老诱导。特别是, 我们专注于测量溶酶体与衰老相关的β-乳糖酶 (SA β-加仑) 的活性, 使用 5-乙炔-2 '-脱氧尿苷 () 的 DNA 合成率, 细胞周期的表达水平抑制剂 p16 和 p21, 以及衰老相关分泌表型 (SASP) 成员的表达和分泌。最后, 给出了实例结果, 并讨论了这些协议的进一步应用。

衰老成纤维细胞中 SA β-gal 染色的富集
β-乳糖酶 (β-加仑) 是一种酶, 表达在所有细胞和具有最佳 pH 值为 4.025,26。然而, 在衰老过程中, 溶酶体体积增大, 衰老细胞积累β-加仑。这种酶的增加使它有可能检测到它的活性, 即使在次优 pH 值 6.025,27?...

Watch this Scientific Journal Video about Induction and Validation of Cellular Senescence in Primary Human Cells at JoVE.com

Induction and Validation of Cellular Senescence in Primary Human Cells

原发性细胞衰老的诱导与鉴定

在这里, 我们讨论了一系列的诱导和确认细胞衰老在培养细胞的协议。我们专注于不同的衰老诱发刺激, 并描述了常见的衰老相关标记的量化。我们提供的技术细节, 以成纤维细胞作为模型, 但协议可以适应各种细胞模型。

Cellular senescence is a state of permanent cell cycle arrest activated in response to different damaging stimuli. Activation of cellular senescence is a ...

induction-and-validation-of-cellular-senescence-in-primary-human-cells

Research

Education

JoVE Journal

JoVE Core

Cell Biology

Developmental Biology

Unit 1

Cell Proliferation

SCIENTISTS IN ACTION

16.7K 次观看.  University of Groningen, University Medical Center Groningen. 在这里, 我们讨论了一系列的诱导和确认细胞衰老在培养细胞的协议。我们专注于不同的衰老诱发刺激, 并描述了常见的衰老相关标记的量化。我们提供的技术细节, 以成纤维细胞作为模型, 但协议可以适应各种细胞模型。

视频: Induction and Validation of Cellular Senescence in Primary Human Cells

Collection of Serum- and Feeder-free Mouse Embryonic Stem Cell-conditioned Medium for a Cell-free Approach

The capacity of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) to generate various cell types has opened new avenues in the field of regenerative medicine. However, despite their benefits, the tumorigenic potential of ESCs and iPSCs has long been a barrier for clinical applications. Interestingly, it has been shown that ESCs produce several soluble factors that can promote tissue regeneration and delay cellular aging, suggesting that ESCs and iPSCs can also be utilized as a cell-free intervention method. Therefore, the method for harvesting mouse embryonic stem cell (mESC)-conditioned medium (mESC-CM) with minimal contamination of serum components (fetal bovine serum, FBS) and feeder cells (mouse embryonic fibroblasts, MEFs) has been highly demanded. Here, the present study demonstrates an optimized method for the collection of mESC-CM under serum- and feeder-free conditions and for the characterization of mESC-CM using senescence-associated multiple readouts. This protocol will provide a method to collect pure mESC-specific secretory factors without serum and feeder contamination.

This protocol provides a method for the collection of mouse embryonic stem cell (mESC)-conditioned medium (mESC-CM) derived from serum (fetal bovine serum, FBS)- and feeder (mouse embryonic fibroblasts, MEFs)-free conditions for a cell-free approach. It may be applicable for the treatment of aging and aging-associated diseases.

和无血清收集无饲养小鼠胚胎干细胞条件培养基的无细胞方法

The capacity of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) to generate various cell types has opened new avenues in the field ...

科研

发育生物学

Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle

Cellular senescence is a stress response that is characterized by a stable cellular growth arrest, which is important for many physiological and pathological processes, such as cancer and ageing. Recently, senescence has also been implicated in tissue repair and regeneration. Therefore, it has become increasingly critical to identify senescent cells in vivo. Senescence-associated &#946;-galactosidase (SA-&#946;-Gal) assay is the most widely used assay to detect senescent cells both in culture and in vivo. This assay is based on the increased lysosomal contents in the senescent cells, which allows the histochemical detection of lysosomal &#946;-galactosidase activity at suboptimum pH (6 or 5.5). In comparison with other assays, such as flow cytometry, this allows the identification of senescent cells in their resident environment, which offers valuable information such as the location relating to the tissue architecture, the morphology, and the possibility of coupling with other markers via immunohistochemistry&#160;(IHC). The major limitation of the SA-&#946;-Gal assay is the requirement of fresh or frozen samples.
Here, we present a detailed protocol to understand how cellular senescence promotes cellular plasticity and tissue regeneration in vivo. We use SA-&#946;-Gal to detect senescent cells in the skeletal muscle upon injury, which is a well-established system to study tissue regeneration. Moreover, we use&#160;IHC to detect Nanog, a marker of pluripotent stem cells, in a transgenic mouse model. This protocol enables us to examine and quantify cellular senescence in the context of induced cellular plasticity and in vivo reprogramming.

Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle

Here we present a detailed protocol to detect both senescent and pluripotent stem cells in the skeletal muscle upon injury while inducing in vivo reprogramming. This method is suitable for evaluating the role of cellular senescence during tissue regeneration and reprogramming in vivo.

骨骼肌损伤诱导衰老和体内重编程的评价

Cellular senescence is a stress response that is characterized by a stable cellular growth arrest, which is important for many physiological and ...

A Sensitive Method to Quantify Senescent Cancer Cells

Human cells do not indefinitely proliferate. Upon external and/or intrinsic cues, cells might die or enter a stable cell cycle arrest called senescence. Several cellular mechanisms, such as telomere shortening and abnormal expression of mitogenic oncogenes, have been shown to cause senescence. Senescence is not restricted to normal cells; cancer cells have also been reported to senesce.
	Chemotherapeutical drugs have been shown to induce senescence in cancer cells. However, it remains controversial whether senescence prevents or promotes tumorigenesis. As it might eventually be patient-specific, a rapid and sensitive method to assess senescence in cancer cell will soon be required.
	To this end, the standard &beta;-galactosidase assay, the currently used method, presents major drawbacks: it is time consuming and not sensitive. We propose here a flow cytometry-based assay to study senescence on live cells. This assay offers the advantage of being rapid, sensitive, and can be coupled to the immunolabeling of various cellular markers.

Whether senescence prevents or promotes tumorigenesis remains controversial. Since chemotherapeutical drugs can induce cancer cells to senesce, studying senescence is essential for proposing new therapies. However, the standard and broadly used &beta;-galactosidase assay presents major drawbacks. We propose here a rapid and sensitive flow cytometry-based assay to quantify senescence.

量化衰老癌症细胞的敏感方法

Human cells do not indefinitely proliferate. Upon external and/or intrinsic  cues, cells might die or enter a stable cell cycle arrest called senescence. ...

医学

A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence

Cellular senescence has been considered a state of irreversible growth arrest upon exhaustion of proliferative capacity or exposure to various stresses. Recent studies have extended the role of cellular senescence to various physiological processes, including development, wound healing, immune surveillance, and age-related tissue dysfunction. Although cell cycle arrest is a critical hallmark of cellular senescence, an increased intracellular reactive oxygen species (ROS) production has also been demonstrated to play an important role in the induction of cellular senescence. In addition, recent studies revealed that senescent cells exhibit potent paracrine activities on neighboring cells and tissues through a senescence-associated secretory phenotype (SASP). The sharp increase in interest regarding therapeutic strategies against cellular senescence emphasizes the need for a precise understanding of senescence mechanisms, including intracellular ROS and the SASP. Here, we describe protocols for quantitatively assessing intracellular ROS levels during H-Ras-induced cellular senescence using ROS-sensitive fluorescent dye and flow cytometry. In addition, we introduce sensitive techniques for the analysis of the induction of mRNA expression and secretion of SASP factors. These protocols can be applied to various cellular senescence models.

Intracellular ROS has been shown to play an important role in the induction of cellular senescence. Here, we describe a sensitive assay for quantifying ROS levels during cellular senescence. We also provide protocols for assessing the senescence-associated secretory phenotype, which reportedly contributes to various age-related dysfunctions.

基因型衰老过程中正常人成纤维细胞活性氧和衰老相关分泌表型的定量测定

Cellular senescence has been considered a state of irreversible growth arrest upon exhaustion of proliferative capacity or exposure to various stresses. ...

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Chemotherapeutic drugs can induce irreparable DNA damage in cancer cells, leading to apoptosis or premature senescence. Unlike apoptotic cell death, senescence is a fundamentally different machinery restraining&#160;propagation of cancer cells. Decades of scientific studies have revealed the complex pathological effects of senescent cancer cells in tumors and microenvironments that modulate cancer cells and stromal cells. New evidence suggests that senescence is a potent prognostic factor during cancer treatment, and therefore rapid and accurate detection of senescent cells in cancer samples is essential. This paper presents a method to visualize and detect therapy-induced senescence (TIS) in cancer cells. Diffuse large B-cell lymphoma (DLBCL) cell lines were treated with mafosfamide (MAF) or daunorubicin (DN) and examined for the senescence marker, senescence-associated &#946;-galactosidase (SA-&#946;-gal), the DNA synthesis marker 5-ethynyl-2&#8242;-deoxyuridine (EdU), and the DNA damage marker gamma-H2AX (&#947;H2AX). Flow cytometer imaging can help generate high-resolution single-cell images in a short period of time to simultaneously visualize and quantify the three markers in cancer cells.

Here we present a flow cytometry-based method for visualization and quantification of multiple senescence-associated markers in single cells.

基于同步成像和流式细胞术检测治疗诱导的衰老癌细胞中的多种荧光衰老标志物

Chemotherapeutic drugs can induce irreparable DNA damage in cancer cells, leading to apoptosis or premature senescence. Unlike apoptotic cell death, ...

癌症研究

Far-Red Fluorescent Senescence-Associated &#946;-Galactosidase Probe for Identification and Enrichment of Senescent Tumor Cells by Flow Cytometry

Cellular senescence is a state of proliferative arrest induced by biological damage that normally accrues over years in aging cells but may also emerge rapidly in tumor cells as a response to damage induced by various cancer treatments. Tumor cell senescence is generally considered undesirable, as senescent cells become resistant to death and block tumor remission while exacerbating tumor malignancy and treatment resistance. Therefore, the identification of senescent tumor cells is of ongoing interest to the cancer research community. Various senescence assays exist, many based on the activity of the well-known senescence marker, senescence-associated beta-galactosidase (SA-&#946;-Gal). 
Typically, the SA-&#946;-Gal assay is performed using a chromogenic substrate (X-Gal) on fixed cells, with the slow and subjective enumeration of "blue" senescent cells by light microscopy. Improved assays using cell-permeant, fluorescent SA-&#946;-Gal substrates, including C12-FDG (green) and DDAO-Galactoside (DDAOG; far-red), have enabled the analysis of living cells and allowed the use of high-throughput fluorescent analysis platforms, including flow cytometers. C12-FDG is a well-documented probe for SA-&#946;-Gal, but its green fluorescent emission overlaps with intrinsic cellular autofluorescence (AF) that arises during senescence due to the accumulation of lipofuscin aggregates. By utilizing the far-red SA-&#946;-Gal probe DDAOG, green cellular autofluorescence can be used as a secondary parameter to confirm senescence, adding reliability to the assay. The remaining fluorescence channels can be used for cell viability staining or optional fluorescent immunolabeling.
Using flow cytometry, we demonstrate the use of DDAOG and lipofuscin autofluorescence as a dual-parameter assay for the identification of senescent tumor cells. Quantitation of the percentage of viable senescent cells is performed. If desired, an optional immunolabeling step may be included to evaluate cell surface antigens of interest. Identified senescent cells can also be flow cytometrically sorted and collected for downstream analysis. Collected senescent cells can be immediately lysed (e.g., for immunoassays or 'omics analysis) or further cultured.

A protocol for fluorescent, flow cytometric quantification of senescent cancer cells induced by chemotherapy drugs in cell culture or in murine tumor models is presented. Optional procedures include co-immunostaining, sample fixation to facilitate large batch or time point analysis, and the enrichment of viable senescent cells by flow cytometric sorting.

远红荧光衰老相关β-半乳糖苷酶探针，用于通过流式细胞术鉴定和富集衰老肿瘤细胞

Cellular senescence is a state of proliferative arrest induced by biological damage that normally accrues over years in aging cells but may also emerge ...

Measurement of Protein Turnover Rates in Senescent and Non-Dividing Cultured Cells with Metabolic Labeling and Mass Spectrometry

Mounting evidence has shown that the accumulation of senescent cells in the central nervous system contributes to neurodegenerative disorders such as Alzheimer&#39;s and Parkinson&#39;s diseases. Cellular senescence is a state of permanent cell cycle arrest that typically occurs in response to exposure to sub-lethal stresses. However, like other non-dividing cells, senescent cells remain metabolically active and carry out many functions that require unique transcriptional and translational demands and widespread changes in the intracellular and secreted proteomes. Understanding how protein synthesis and decay rates change during senescence can illuminate the underlying mechanisms of cellular senescence and find potential therapeutic avenues for diseases exacerbated by senescent cells. This paper describes a method for proteome-scale evaluation of protein half-lives in non-dividing cells using pulsed stable isotope labeling by amino acids in cell culture (pSILAC) in combination with mass spectrometry. pSILAC involves metabolic labeling of cells with stable heavy isotope-containing versions of amino acids. Coupled with modern mass spectrometry approaches, pSILAC enables the measurement of protein turnover of hundreds or thousands of proteins in complex mixtures. After metabolic labeling, the turnover dynamics of proteins can be determined based on the relative enrichment of heavy isotopes in peptides detected by mass spectrometry. In this protocol, a workflow is described for the generation of senescent fibroblast cultures and similarly arrested quiescent fibroblasts, as well as a simplified, single-time point pSILAC labeling time-course that maximizes coverage of anticipated protein turnover rates. Further, a pipeline is presented for the analysis of pSILAC mass spectrometry data and user-friendly calculation of protein degradation rates using spreadsheets. The application of this protocol can be extended beyond senescent cells to any non-dividing cultured cells such as neurons.

This protocol describes the workflow for metabolic labeling of senescent and non-dividing cells with pulsed SILAC, untargeted mass spectrometry analysis, and a streamlined calculation of protein half-lives.

使用代谢标记和质谱法测量衰老和非分裂培养细胞中的蛋白质周转率

Mounting evidence has shown that the accumulation of senescent cells in the central nervous system contributes to neurodegenerative disorders such as ...

生物化学

Techniques to Induce and Quantify Cellular Senescence

In response to cellular stress or damage, proliferating cells can induce a specific program that initiates a state of long-term cell-cycle arrest, termed cellular senescence. Accumulation of senescent cells occurs with organismal aging and through continual culturing in vitro. Senescent cells influence many biological processes, including embryonic development, tissue repair and regeneration, tumor suppression, and aging. Hallmarks of senescent cells include, but are not limited to, increased senescence-associated &#946;-galactosidase activity (SA-&#946;-gal); p16INK4A, p53, and p21 levels; higher levels of DNA damage, including &#947;-H2AX; the formation of Senescence-associated Heterochromatin Foci (SAHF); and the acquisition of a Senescence-associated Secretory Phenotype (SASP), a phenomenon characterized by the secretion of a number of pro-inflammatory cytokines and signaling molecules. Here, we describe protocols for both replicative and DNA damage-induced senescence in cultured cells. In addition, we highlight techniques to monitor the senescent phenotype using several senescence-associated markers, including SA-&#946;-gal, &#947;-H2AX and SAHF staining, and to quantify protein and mRNA levels of cell cycle regulators and SASP factors. These methods can be applied to the assessment of senescence in various models and tissues.

Cellular senescence, the irreversible state of cell-cycle arrest, can be induced by various cellular stresses. Here, we describe protocols to induce cellular senescence and methods to assess markers of senescence.

技术诱导和量化细胞衰老

In response to cellular stress or damage, proliferating cells can induce a specific program that initiates a state of long-term cell-cycle arrest, termed ...

生物学

SA-&#946;-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Cell senescence is one of the hallmarks of aging known to negatively influence a healthy lifespan. Drugs able to kill senescent cells specifically in cell culture, termed senolytics, can reduce the senescent cell burden in vivo and extend healthspan. Multiple classes of senolytics have been identified to date including HSP90 inhibitors, Bcl-2 family inhibitors, piperlongumine, a FOXO4 inhibitory peptide and the combination of Dasatinib/Quercetin. Detection of SA-&#946;-Gal at an increased lysosomal pH is one of the best characterized markers for the detection of senescent cells. Live cell measurements of senescence-associated &#946;-galactosidase (SA-&#946;-Gal) activity using the fluorescent substrate C12FDG in combination with the determination of the total cell number using a DNA intercalating Hoechst dye opens the possibility to screen for senotherapeutic drugs that either reduce overall SA-&#946;-Gal activity by killing of senescent cells (senolytics) or by suppressing SA-&#946;-Gal and other phenotypes of senescent cells (senomorphics). Use of a high content fluorescent image acquisition and analysis platform allows for the rapid, high throughput screening of drug libraries for effects on SA-&#946;-Gal, cell morphology and cell number.

Cellular senescence is the key factor in the development of chronic age-related pathologies. Identification of therapeutics that target senescent cells show promise for extending healthy aging. Here, we present a novel assay to screen for the identification of senotherapeutics based on measurement of senescence associated &#946;-Galactosidase activity in single cells.

SA-β-加拉基沙酶筛查检测,用于识别治疗药物

Cell senescence is one of the hallmarks of aging known to negatively influence a healthy lifespan. Drugs able to kill senescent cells specifically in cell ...